Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people stay on 5mg Mounjaro for four weeks before their prescriber considers moving to the next dose. That four-week minimum is built into the licensed titration schedule, giving your body time to settle and your prescriber enough information to decide whether you're ready to increase. Mounjaro is a prescription-only medicine, so any change to your dose is a clinical decision made with a registered prescriber, not something to adjust alone. Here is what that process actually looks like, and why it matters more than most people initially expect.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The scenario is a familiar one. You moved from 2.5mg without much drama, your appetite has shifted noticeably, and now you're asking whether you should push on to 7.5mg or sit where you are for a while longer. It's a reasonable question, and the honest answer is: it depends on a combination of factors only your prescriber can assess.
The licensed schedule for tirzepatide, as set out in the Mounjaro SmPC on the eMC, places a minimum of four weeks at each dose. That isn't an arbitrary waiting period. The 5mg dose takes several weeks to reach a steady state in your system, and side effects that feel prominent in week one often settle considerably by week three or four. Judging whether a dose is working well before that point is genuinely difficult.
One thing worth saying plainly: staying on 5mg for longer than four weeks is not a sign that something has gone wrong. A prescriber might recommend it if you're still managing some nausea, if your weight loss is progressing steadily and comfortably, or simply because there is no clinical reason to move faster. The titration ladder exists to protect you, not to be climbed as quickly as possible. More on the specific decision around whether to hold at this dose is covered on our guide to staying on 5mg Mounjaro.
Your prescriber will consider several things together. Tolerability comes first. If gastrointestinal symptoms (nausea, loose stools, reflux, a sense of fullness that goes beyond reduced appetite) are still significant at the end of your first 5mg pen, moving to 7.5mg is likely to intensify them, at least initially. Staying put until things settle is the more comfortable and usually the safer path.
Weight response is the second consideration. The NHS tirzepatide page notes that if you haven't lost at least 5% of your body weight after six months at the highest dose you can tolerate, continuing treatment should be reviewed. That benchmark applies across the full course, and our page on how long to stay on 5mg Mounjaro goes into more detail about how to think through that timing with your prescriber.
A common misconception is that higher always means better. Many people find that 5mg produces meaningful, consistent weight loss with fewer side effects than a higher dose would bring, and for some it remains the right maintenance level for months. If you're also curious about how this treatment interacts with hormones, our page exploring whether Mounjaro increases estrogen addresses some of the questions we hear most often on that topic. The medicine's job is to help you reach and hold a healthier weight, and the dose that does that with the least disruption is the right one for you, not necessarily the largest one available.
If you'd like to understand more about what this treatment costs as part of a private prescription, our Mounjaro cost page sets out what a private prescription typically includes.
Every repeat at nume goes back to a GPhC-registered Independent Prescriber. A real clinician reads your update before anything is dispensed. That review considers your current dose, any side effects you've reported, your weight progress, and whether the next step up is appropriate or whether holding at 5mg makes more sense for another four-week cycle.
This matters because dose increases are not without consequence. Moving from 5mg to 7.5mg typically brings a temporary return of gastrointestinal symptoms as your body adjusts again. If those symptoms were still lingering at the end of your 5mg pen, an increase is unlikely to feel comfortable straight away. For people earlier in their journey who are still on the starting dose, our pages on whether to stay on 2.5mg Mounjaro and how long to stay on 2.5mg Mounjaro cover the same kind of thinking at that stage. A prescriber who knows your history can make that call accurately; a system that auto-ships the next pen without a review cannot.
There is no fixed answer to how long you should stay on 5mg Mounjaro that applies to every person. Four weeks is the floor set by the licensed schedule. Beyond that, it is your prescriber's assessment (based on tolerability, progress and your overall health picture) that determines the right moment to move. Our frequently asked questions cover a range of related dosing queries if you want to read further, and our clinical team oversees all prescribing at nume. If you're ready to talk through where you are in treatment, you can check your eligibility and start a free consultation at any point.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.